FDA grants regular approval to sacituzumab govitecan for triple-negative breast cancer.On April 7, 2021, the Food and Drug Administration granted regular approval to sacituzumab govitecan (Trodelvy, Immunomedics Inc.) for patients with unresectable locally advanced or metastatic more...
Demega formulations India is a major exporter of Xovoltib (Afatinib), is used to treat metastatic non-small cell lung cancer . there is emerging evidence to support Xovoltib use in other cancers such as breast cancer We assure quality of product of long expiration date and ship imore...
Demega formulations India is a major exporter of Xovoltib (Afatinib), is used to treat metastatic non-small cell lung cancer . there is emerging evidence to support Xovoltib use in other cancers such as breast cancer We assure quality of product of long expiration date and ship imore...